SEC Form 4 · accession 0001209191-15-084885
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Director
Period of report
Dec 10, 2015
Accepted (ET)
Dec 14, 2015 · 11:52 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 10, 2015 | P | 15,379 | $7.2308 | A | 34,979 | I | Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust |
| Common StockF2 | Dec 11, 2015 | P | 4,621 | $7.298 | A | 39,600 | I | Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust |
| Common Stock | holding | — | — | — | 39,600 | I | Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust | |
| Common Stock | holding | — | — | — | 5,000 | I | By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA | |
| Common Stock | holding | — | — | — | 13,514 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $7.01 to $7.53 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F2Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $7.16 to $7.43 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.